Dergiler / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2021 / Cilt: 29 - Sayı: 1

Mid-term results of tunneled brachial venous hemodialysis catheter placement: Our single-center experience with 21 patients

Tünelli brakiyal venöz hemodiyaliz kateter yerleştirmesinin orta dönem sonuçları: 21 hasta ile tek merkezli deneyimimiz

Sayfa
13–19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our study results show that brachial venous tunneled catheter placement for hemodialysis can be a safe and valid alternative to catheter insertion from the jugular or subclavian veins for vascular access in patients with end-stage renal disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:of permanent hemodialysis catheter insertion via the brachial vein in unsuitable patients for catheter insertion from other vascular access sites.
📊
Temel Bulgular & Veri:Methods: A total of 21 patients (6 males, 18 females; mean age: 54.4±11.3 years; range, 48 to 77 years) who underwent permanent hemodialysis catheter insertion via the brachial vein between February 2019 and February 2020 were retrospectively analyzed.
💡
Sonuç & Katkı:Conclusion: Our study results show that brachial venous tunneled catheter placement for hemodialysis can be a safe and valid alternative to catheter insertion from the jugular or subclavian veins for vascular access in patients with end-stage renal disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

of permanent hemodialysis catheter insertion via the brachial vein in unsuitable patients for catheter insertion from other vascular access sites. Methods: A total of 21 patients (6 males, 18 females; mean age: 54.4±11.3 years; range, 48 to 77 years) who underwent permanent hemodialysis catheter insertion via the brachial vein between February 2019 and February 2020 were retrospectively analyzed. All patients underwent brachial venous tunneled catheter insertion under the ultrasound guidance and under local anesthesia. Transthoracic echocardiography was performed before and six months after catheter insertion. The primary patency rate of the catheter at six months of follow-up, potential associated complications of a permanent hemodialysis catheter including catheter thrombosis and catheter infections, and all-cause mortality rates were recorded. Results: Catheter removal was required in eight patients (catheter thrombosis, n=5; catheter infection, n=2; and extensive hematoma, n=1). The catheters were patent in the remaining 13 (62%) patients at six months. Mortality occurred in one patient due to bacterial pneumonia. No life-threatening complications including hemothorax or pneumothorax and neurological injury was observed in any of the patients. Conclusion: Our study results show that brachial venous tunneled catheter placement for hemodialysis can be a safe and valid alternative to catheter insertion from the jugular or subclavian veins for vascular access in patients with end-stage renal disease.

Abstract

Amaç: Bu çalışmada diğer vasküler erişim bölgelerinden kateter yerleştirme işlemine uygun olmayan hastalarda brakiyel venden kalıcı hemodiyaliz kateter yerleştirilmesinin güvenliliği ve etkinliği değerlendirildi. Çalışma planı: Şubat 2019-Şubat 2020 tarihleri arasında brakiyel venden kalıcı hemodiyaliz kateteri yerleştirilen toplam 21 hasta (6 erkek, 18 kadın; ort. yaş: 54.4±11.3 yıl; dağılım, 48-77 yıl) retrospektif olarak incelendi. Hastaların tümüne ultrason eşliğinde ve lokal anestezi ile brakiyel venöz tünelli kateter yerleştirme işlemi yapıldı. Kateter yerleştirilmesinden önce ve altı ay sonra transtorasik ekokardiyografi çekildi. Takibin altıncı ayında kateterin primer açıklık oranı, kateter trombozu ve kateter enfeksiyonları gibi kalıcı hemodiyaliz kateteri ile ilişkili muhtemel komplikasyonlar ve tüm nedenlere bağlı mortalite oranları kaydedildi. Bulgular: Sekiz hastada kateterin çıkarılması gerekti (n=5 kateter trombozu, n=2 kateter enfeksiyonu ve n=1 büyük hematom). Altıncı ayda geriye kalan 13 hastada (%62) kateterler açıktı. Bir hastada bakteriyel pnömoniye bağlı mortalite izlendi. Hastaların hiçbirinde hemotoraks veya pnömonotoraks gibi yaşamı tehdit eden komplikasyonlar ve nörolojik hasar görülmedi. Sonuç: Çalışma sonuçlarımız, hemodiyaliz için brakiyel venöz tünelli kateter yerleştirilmesinin, son dönem böbrek hastalığı olan hastalarda, juguler veya subklavyen venlerden yapılan kateter yerleştirilmesine güvenli ve geçerli bir alternatif olabileceğini göstermektedir.

🔖

Bu Makaleye Atıf Yap

KHALIL, E. (2021). Mid-term results of tunneled brachial venous hemodialysis catheter placement: Our single-center experience with 21 patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 29 - Sayı: 1, 13–19. https://ajindex.com/articles/402097

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. DeVita MV, Khine SK, Shivarov H. Novel approaches to arteriovenous access creation, maturation, suitability, and durability for dialysis. Kidney Int Rep 2020;5:769-78
  2. Lacson E Jr, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM. Balancing fistula first with catheters last. Am J Kidney Dis 2007;50:379-95
  3. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg 2008;47:415-21
  4. Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, et al. Vascular access practice patterns in canada: A national survey. Can J Kidney Health Dis 2018;5:2054358118759675
  5. Raji YR, Ajayi SO, Aminu O, Abiola B, Efuntoye O, Salako BL, et al. Outcomes of tunneled internal jugular venous catheters for chronic haemodialysis at the University College Hospital, Ibadan, Nigeria. Pan Afr Med J 2018;31:218
  6. Pašara V, Maksimović B, Gunjača M, Mihovilović K, Lončar A, Kudumija B, et al. Tunnelled haemodialysis catheter and haemodialysis outcomes: a retrospective cohort study in Zagreb, Croatia. BMJ Open 2016;6:e009757
  7. Özbudak E, Eraldemir FC, Arıkan AA, Şahin D, Maral Kır H, Kurt T, et al. An evaluation of rivaroxaban and clopidogrel in a rat lower extremity ischemia-reperfusion model: An experimental study. Turk Gogus Kalp Dama 2019;27:513-20
  8. Santoro D, Benedetto F, Mondello P, Pipitò N, Barillà D, Spinelli F, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis 2014;7:281-94
  9. Wanner C, Ketteler M. Chronic kidney disease. Dtsch Med Wochenschr 2017;142:193-6
  10. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017;389:1238-52
  11. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet 2016;388:294-306
  12. Coentrão L, Van Biesen W, Nistor I, Tordoir J, Gallieni M, Marti Monros A, et al. Preferred haemodialysis vascular access for diabetic chronic kidney disease patients: A systematic literature review. J Vasc Access 2015;16:259-64
  13. Thalhammer C, Segerer S. Hemodialysis vascular access. Dtsch Med Wochenschr 2014;139:1562-4
  14. Hayashi R, Huang E, Nissenson AR. Vascular access for hemodialysis. Nat Clin Pract Nephrol 2006;2:504-13
  15. Dumaine CS, Brown RS, MacRae JM, Oliver MJ, Ravani P, Quinn RR. Cen